Stock 874 GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDING CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.

Equities

874

CNE100000387

Pharmaceuticals

Delayed Hong Kong S.E.
Other stock markets
 09:08:20 14/05/2024 BST 		5-day change 1st Jan Change
23.05 HKD +0.22% Intraday chart for Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd. +6.47% +5.98%
04-26 Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-15 Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd. specializes in researching, developing and manufacturing pharmaceutical products. The group's products include analgesics, antibiotics, medicines for the treatment of stomach disorders, treatment of cough, antitoxic products, etc.

Number of employees: 28,048

Sales per Business

HKD in Million2022Weight2023Weight Delta
Big Business
70.0 %
57,315 69.6 % 58,448 70.0 % +1.98%
Great Health
14.7 %
12,199 14.8 % 12,300 14.7 % +0.83%
Great Southern Medicine
14.5 %
12,242 14.9 % 12,124 14.5 % -0.96%
Other
0.7 %
562 0.7 % 572 0.7 % +1.66%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
99.5 %
82,286 100.0 % 83,064 99.5 % +0.95%
Other Countries
0.5 %
32 0.0 % 380 0.5 % +1,089.00%

Managers

Managers TitleAgeSince
Hong Li CEO
 Chief Executive Officer 57 22/06/17
Rui Yu Cai CHM
 Chairman 57 -
Chun Bo Zhang BRD
 Director/Board Member 47 31/12/14
Chang Hai Wu BRD
 Director/Board Member 58 27/06/10
Hao Shan Zheng PRN
 Corporate Officer/Principal 48 -
Jian Xiong Zheng PRN
 Corporate Officer/Principal 54 -
Xue Zhen Huang SEC
 Corporate Secretary 50 25/04/17

Members of the board

Members of the board TitleAgeSince
Lung Tak Wong BRD
 Director/Board Member 76 27/06/10
Ju Yan Liu BRD
 Director/Board Member 59 30/11/13
Hong Li CEO
 Chief Executive Officer 57 22/06/17
Chun Bo Zhang BRD
 Director/Board Member 47 31/12/14
Rui Yu Cai CHM
 Chairman 57 -
Jin Yuan Cheng BRD
 Director/Board Member 51 12/01/20
Ya Jin Chen BRD
 Director/Board Member 61 28/06/20
Min Huang BRD
 Director/Board Member 60 28/06/20
Hui Dong Jian BRD
 Director/Board Member 51 02/06/21
Bao Qing Sun BRD
 Director/Board Member 53 29/05/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,405,890,949 582,176,011 ( 41.41 %) 0 49.33 %
Stock B 1 219,900,000 219,900,000 ( 100.00 %) 0

Shareholders

NameEquities%Valuation
Norges Bank Investment Management
16.04 %
35,281,000 16.04 % 94 M $
LSV Asset Management
5.996 %
13,186,111 5.996 % 35 M $
HBM Partners AG (Investment Management)
1.186 %
2,609,000 1.186 % 7 M $
MC China Ltd. (Investment Management)
0.5984 %
1,315,986 0.5984 % 4 M $
China Merchants Fund Management Co., Ltd.
0.2711 %
596,193 0.2711 % 2 M $
State Street Global Advisors Ltd.
0.2275 %
500,209 0.2275 % 1 M $
Generali Investments LLC
0.1594 %
350,548 0.1594 % 936 741 $
Focusbridge Investments Ltd.
0.1592 %
350,000 0.1592 % 935 277 $
AXA Investment Managers Asia (Singapore) Ltd.
0.1382 %
304,000 0.1382 % 812 355 $
LähiTapiola Varainhoito Oy
0.0937 %
206,000 0.0937 % 550 477 $
NameEquities%Valuation
Guangzhou State-Owned Assets Supervision & Admin. Commission
53.43 %
751,138,850 53.43 % 3 328 M $
Guangzhou Chengfa Investment Capital Management Co. Ltd.
5.215 %
73,313,783 5.215 % 325 M $
China Securities Finance Corp. Ltd.
3.363 %
47,277,962 3.363 % 209 M $
China Southern Asset Management Co., Ltd.
0.6187 %
8,698,464 0.6187 % 39 M $
Zhong Ou Asset Management Co., Ltd
0.5533 %
7,778,270 0.5533 % 34 M $
Hongde Fund Management Co., Ltd.
0.5126 %
7,206,353 0.5126 % 32 M $
China Asset Management Co., Ltd.
0.4664 %
6,557,417 0.4664 % 29 M $
GF Fund Management Co., Ltd.
0.2462 %
3,461,213 0.2462 % 15 M $
Rongtong Fund Management Co., Ltd.
0.2382 %
3,348,923 0.2382 % 15 M $
Fullgoal Fund Management Co., Ltd.
0.2309 %
3,246,348 0.2309 % 14 M $

Holdings

NameEquities%Valuation
YIXINTANG PHARMACEUTICAL GROUP CO., LTD.
7.72%
 30,880,304 7.72% 89,892,565 $
C.Q. PHARMACEUTICAL HOLDING CO., LTD.
1.50%
 25,992,330 1.50% 19,562,087 $
CHARMACY PHARMACEUTICAL CO., LTD.
1.00%
 1,080,000 1.00% 1,933,211 $

Company contact information

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.

No. 45 Sha Mian North Street Liwan District

510130, Guangzhou

+86 20 6628 1011

http://www.gybys.com.cn
address Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.(874)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
21.34 CNY
Average target price
22.1 CNY
Spread / Average Target
+3.55%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDING CO., LTD. Stock Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.
+5.98% 7.08B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+31.06% 688B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.35% 588B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.42% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.02% 326B
ABBVIE INC. Stock AbbVie Inc.
+4.27% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.53% 239B
NOVARTIS AG Stock Novartis AG
+10.16% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-8.14% 200B
AMGEN INC. Stock Amgen Inc.
+8.12% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 874 Stock
  4. Company Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.